Entrepreneurship recognition IWD2019
Electrospinning’s CEO Ann Kramer was honoured to be invited to a reception for female entrepreneurs at 10 Downing Street to mark International Women’s Day. Ann was selected to meet the prime minister and was delighted to introduce the Company, with a particular focus on the potential for electrospun biomaterials to address problems in gynecological health.
Expanded and Diverse Team
We are pleased to have added new members to our team and are proud of the diversity in the company. Our 50/50 gender balanced team of 14 people has representatives from 9 nationalities and ages from every decade from 20s to 60s. We apply this diversity of approach and background to innovation and problem-solving. In March… Read more »
UK Top 10 Healthcare Scale-ups to watch list
The Electrospinning Company has been recognised as one of Britain’s top 10 scale-up companies to watch in healthcare and life sciences, in a list compiled by Capital Cell Investment Manager. More information can be found here.
Appointment of chair
The Electrospinning Company has appointed Dr Stewart White as non-executive chairman. Previously CEO of two life science AIM-quoted companies including Collagen Solutions plc, Stewart is currently CEO of Novel Technologies Holdings Limited and Chairman of Mikota Ltd. Stewart has international executive experience in commercialisation, product development, GMP manufacturing of medical devices, advanced biologics and API’s in both SMEs… Read more »
Innovation Loan for manufacturing scale-up
One of 17 businesses backed in the second round of innovation loans for innovative manufacturing processes and materials. The companies will use the funding to carry out R&D projects as part of plans to scale up production and commercialise new technologies. The Electrospinning Company has just moved into purpose-built clean-room facilities on the growing Harwell Science and Innovation… Read more »
Brand new, purpose-built facilities on the Harwell Science and Innovation Campus, a rapidly expanding innovation hub near Oxford in the UK. We are moving into our new unit (#5) in the Zephyr Building on 29th October. The 500 square metre unit is fitted out with four Class VII cleanroom modules, facilitating the segregation of R&D… Read more »
Multiple sclerosis repair roadmap
Research published in the journal Nature provides new understanding about how drugs can repair damaged brain cells that cause disability in patients with multiple sclerosis. Led by researchers at Case Western Reserve University School of Medicine, the study suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis… Read more »
Quality and Project Management Vacancies
Join our expanding team as we move into brand new cleanroom facilities. We are looking for a Quality and Project Managers: TECL Quality Manager TECL017 November 2018 and Project Manager TECL Project Manager Vacancy TECL018 Nov 2018 v1.0 to join our growing team as we move into brand new, purpose-built facilities. Sorry – we can’t obtain visas for non-Europeans.
Expansion of facilities
The Electrospinning Company is fitting out a new facility in the brand new Zephyr building on Harwell Campus, near Oxford, in responding to a growing demand for electrospun biomaterials in regenerative medical devices. The new larger facility will include modular, state-of-the art cleanrooms for manufacturing, a dedicated design and development laboratory and offices. “This expansion will allow… Read more »
Melt electrospinning arrives at The Electrospinning Company
Part of the BONE project, The Electrospinning Company will be playing a crucial role in translating academic findings using melt electrospinning into clinical-grade products. We are extremely excited to have finally received our melt electrospinning device, work together with our BONE partners towards novel medical devices and expanding our expertise in electrospinning. the Electrospinning Team
ISO 13485:2016 QMS recertification
The Electrospinning Company has updated its Quality Management System to the new ISO 13485:2016 standard for the design, development, manufacture and supply of electrospun polymer scaffolds, and has been re-certified for a further three years. The ISO13485 standard has been updated from 13485:2003 to 13485:2016 to keep up with changes in the medical device industry… Read more »
Biomaterials Risk Management BIORIMA H2020 grant
The Electrospinning Company is a partner in the EU funded H2020 Research and Innovation action BIORIMA (Biomaterial Risk Management). The project aims to develop an integrated risk management framework for nano-biomaterials used in advanced therapeutic medicinal products and medical devices. The BIORIMA risk management framework is a structure upon which the validated tools and methods… Read more »